SLN
Silence Therapeutics plc (SLN)
Last Price$4.3(4.0%)
Market Cap$211.4B
1Y Forward Revenue growth
(27.9%)
1Y Forward EPS growth
18.9%
Last EPS & EPS Surprise
$0.00
100.0% beat
Last 10 Earnings
4 Beat / 6 Miss

SLN Revenue and EPS Expectations

Annual
Quarterly

Revenue

Dec'21Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28$12.4M$17.5M$25.4M$20.7M$27.6M$16.7M$58.2M$163.1M
Revenue actual
Revenue estimate

EPS

Dec'21Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28($1.33)($1.26)($1.17)($0.42)($0.44)($0.57)($0.55)($0.10)
EPS actual
EPS estimate
Dec'21Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28
Revenue growth126.6%41.0%45.0%(27.9%)33.3%(39.5%)247.9%180.3%
EPS growth11.8%(5.3%)(7.1%)18.9%6.0%27.5%(3.3%)(81.8%)

SLN Earnings Surprises

Crunching data... Almost there!

SLN Earnings History

Dec'14Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24
Revenue actual$4,000.0$0.0$0.0$0.0$0.0$0.0$0.0$385.0K$385.0K$8,000.0$8,000.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$122.0K$122.0K$573.0K$573.0K$1,988.0K($842.0K)$3,144.0K$2,701.0K$3,156.0K$3,414.0K$5,722.0K$3,643.0K$3,371.0K$4,765.0K$11.4M$9,104.0K$2,798.0K$2,099.0K$12.4M$598.0K$1,142.0K
Revenue estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$1,609.3K$2,375.0K$2,375.0K$2,375.0K$2,375.0K$2,375.0K$2,375.0K$16.5M$2,493.8K$3,056.2K$2,406.2K$7,083.0K$5,061.2K$9,207.3K$4,374.3K
Revenue surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%95.4%13.7%32.9%43.7%140.9%53.4%41.9%71.1%356.1%197.9%16.3%70.4%145.1%93.5%73.9%
EPS actual($0.16)($0.11)($0.11)($0.05)($0.05)($0.10)($0.10)($0.08)($0.08)($0.12)($0.12)$0.08$0.08($0.19)($0.19)($0.21)($0.21)($0.17)($0.17)($0.22)($0.22)($0.21)($0.21)($0.33)($0.07)($0.29)($0.39)($0.33)($0.32)($0.26)($0.40)($0.22)($0.43)($0.28)($0.29)($0.22)($0.37)($0.04)($0.33)$0.00
EPS estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A($0.58)($0.58)($0.58)($0.58)($0.58)($0.58)($0.58)($0.01)($0.12)($0.14)($0.14)($0.06)($0.10)($0.09)($0.10)
EPS surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%50.2%32.3%42.7%44.4%54.9%30.5%61.8%3,130.7%135.3%109.6%58.9%479.2%55.7%270.5%100.0%

FAQ

1. What is Silence Therapeutics plc (SLN) 1-year forward revenue growth estimate?

Silence Therapeutics plc (SLN) 1-year forward revenue growth is estimated at (27.9%).

2. What is Silence Therapeutics plc (SLN) 1-year forward EPS growth estimate?

Silence Therapeutics plc (SLN) 1-year forward EPS growth is estimated at 18.9%.

3. What was Silence Therapeutics plc (SLN) last EPS, and was there a surprise?

Silence Therapeutics plc (SLN) last reported EPS was $0.00, with a 100.0% beat.

4. What is Silence Therapeutics plc (SLN) performance across the last 10 earnings reports?

Silence Therapeutics plc (SLN) had 4 beats and 6 misses in its last 10 earnings reports.